08:00 , Dec 21, 2009 |  BC Week In Review  |  Company News

Regulus, California Institute of Technology deal

The institute granted Regulus exclusive, worldwide rights to IP covering methods and compositions for modulating microRNA-146 (miR-146) and microRNA-155 (miR-155). The company plans to use the IP to develop RNA-based treatments for inflammatory...